• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾素-血管紧张素系统参与人类血管发生和血管生成的调节吗?

Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis?

作者信息

Khakoo Aarif Y, Sidman Richard L, Pasqualini Renata, Arap Wadih

机构信息

The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

出版信息

Cancer Res. 2008 Nov 15;68(22):9112-5. doi: 10.1158/0008-5472.CAN-08-0851.

DOI:10.1158/0008-5472.CAN-08-0851
PMID:19010879
Abstract

Several lines of evidence suggest that hypertension and angiogenesis may be related phenomena but a functional link remains elusive. Here, we propose that the renin-angiotensin system (RAS), in addition to its central role in arterial hypertension, also regulates blood vessel formation during normal development and cancer. This mechanistic hypothesis is based on reports of biochemical, genetic, clinical, and epidemiologic data reviewed herein. Species differences between the RAS of rodents and humans likely account for why such a fundamental role in angiogenesis went unrecognized for so long. If proven correct, this hypothesis carries many implications for the medical practices of cardiology, oncology, and neonatology.

摘要

多条证据表明高血压和血管生成可能是相关现象,但功能联系仍不明确。在此,我们提出肾素-血管紧张素系统(RAS),除了在动脉高血压中起核心作用外,在正常发育和癌症过程中也调节血管形成。这一机制假说基于本文所综述的生化、遗传、临床和流行病学数据报告。啮齿动物和人类RAS之间的物种差异可能解释了为何血管生成中的这一基本作用长期未被认识。如果这一假说被证明是正确的,将对心脏病学、肿瘤学和新生儿学的医疗实践产生诸多影响。

相似文献

1
Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis?肾素-血管紧张素系统参与人类血管发生和血管生成的调节吗?
Cancer Res. 2008 Nov 15;68(22):9112-5. doi: 10.1158/0008-5472.CAN-08-0851.
2
Diabetes and retinal vascular disorders: role of the renin-angiotensin system.糖尿病与视网膜血管疾病:肾素-血管紧张素系统的作用
Expert Rev Mol Med. 2004 Jul 23;6(15):1-18. doi: 10.1017/S1462399404008129.
3
Effects of the renin angiotensin system on vasculogenesis-related progenitor cells.肾素-血管紧张素系统对血管生成相关祖细胞的影响。
Curr Opin Pharmacol. 2011 Apr;11(2):162-74. doi: 10.1016/j.coph.2011.01.002. Epub 2011 Feb 4.
4
Suppression of renin-angiotensin system attenuates hepatocarcinogenesis via angiogenesis inhibition in rats.抑制肾素-血管紧张素系统通过抑制大鼠血管生成减轻肝癌发生。
Anticancer Res. 2005 Sep-Oct;25(5):3335-40.
5
STAT3: a critical transcription activator in angiogenesis.信号转导与转录激活因子3(STAT3):血管生成中的关键转录激活因子
Med Res Rev. 2008 Mar;28(2):185-200. doi: 10.1002/med.20101.
6
Effects of anti-hypertensive drugs on vessel rarefaction.抗高血压药物对血管稀疏的影响。
Curr Opin Pharmacol. 2007 Apr;7(2):151-7. doi: 10.1016/j.coph.2006.09.007. Epub 2007 Feb 2.
7
[The renin-angiotensin system and post-ischemic angiogenesis].
Bull Acad Natl Med. 2004;188(4):649-59; discussion 659.
8
Newly developed angiotensin II-infused experimental models in vascular biology.血管生物学中最新开发的血管紧张素 II 输注实验模型。
Regul Pept. 2008 Oct 9;150(1-3):1-6. doi: 10.1016/j.regpep.2008.05.002. Epub 2008 May 14.
9
Role of renin angiotensin system in angiogenesis: it is still elusive.肾素-血管紧张素系统在血管生成中的作用:仍不清楚。
Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):622-4. doi: 10.1161/01.ATV.0000125707.94116.a4.
10
Role of bone marrow renin-angiotensin system in the pathogenesis of atherosclerosis.骨髓肾素-血管紧张素系统在动脉粥样硬化发病机制中的作用。
Pharmacol Ther. 2008 May;118(2):268-76. doi: 10.1016/j.pharmthera.2008.02.007. Epub 2008 Mar 10.

引用本文的文献

1
Cancer Stem Cells and the Renin-Angiotensin System in the Tumor Microenvironment of Melanoma: Implications on Current Therapies.黑色素瘤肿瘤微环境中的癌症干细胞与肾素-血管紧张素系统:对当前治疗的启示
Int J Mol Sci. 2025 Feb 6;26(3):1389. doi: 10.3390/ijms26031389.
2
Impact of renin angiotensin system inhibitors on survival of patients with metastatic non-small cell lung cancer.肾素-血管紧张素系统抑制剂对转移性非小细胞肺癌患者生存率的影响。
Ann Saudi Med. 2025 Jan-Feb;45(1):18-24. doi: 10.5144/0256-4947.2025.18. Epub 2025 Feb 6.
3
Reviewing the path to balance: mechanisms and management of hypertension associated with targeting vascular endothelium in cancer therapy.
审视平衡之路:癌症治疗中靶向血管内皮相关高血压的机制与管理
Hypertens Res. 2025 Mar;48(3):1034-1047. doi: 10.1038/s41440-024-02086-8. Epub 2025 Jan 16.
4
Elucidating the Role of Pro-renin Receptors in Pancreatic Ductal Adenocarcinoma Progression: A Novel Therapeutic Target in Cancer Therapy.阐明前肾素受体在胰腺导管腺癌进展中的作用:癌症治疗中的一个新的治疗靶点。
Curr Cancer Drug Targets. 2024;24(9):881-889. doi: 10.2174/0115680096279288231205105904.
5
Association of angiotensin II and receptors in peri-implantation endometrium with microvessel density and pregnancy outcomes of women with recurrent implantation failure after embryo transfer.血管紧张素 II 及其受体在胚胎着床期子宫内膜中的分布与反复胚胎移植失败患者的微血管密度及妊娠结局的关系。
Front Endocrinol (Lausanne). 2023 Aug 29;14:1206326. doi: 10.3389/fendo.2023.1206326. eCollection 2023.
6
The (pro)renin receptor as a pharmacological target in cardiorenal diseaes.(前)肾素受体作为心脏肾脏疾病的药理学靶点。
Hypertens Res. 2023 Nov;46(11):2527-2534. doi: 10.1038/s41440-023-01424-6. Epub 2023 Sep 4.
7
Renin-Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins.肝脏代谢中的肾素-血管紧张素系统:性别差异与肠促胰岛素的作用。
Metabolites. 2022 May 3;12(5):411. doi: 10.3390/metabo12050411.
8
Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在高血压合并食管或胃癌患者中的预后影响 - 一项真实世界研究。
BMC Cancer. 2022 Apr 20;22(1):430. doi: 10.1186/s12885-022-09513-4.
9
Proteomic analysis of peritoneal fluid identified COMP and TGFBI as new candidate biomarkers for endometriosis.蛋白质组学分析腹膜液发现 COMP 和 TGFBI 是子宫内膜异位症的新候选生物标志物。
Sci Rep. 2021 Oct 22;11(1):20870. doi: 10.1038/s41598-021-00299-2.
10
The Role of the Renin-Angiotensin System in the Cancer Stem Cell Niche.肾素-血管紧张素系统在肿瘤干细胞生态位中的作用。
J Histochem Cytochem. 2021 Dec;69(12):835-847. doi: 10.1369/00221554211026295. Epub 2021 Jun 24.